These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21147189)

  • 21. [Myxovirus resistance protein A (MxA) induces the expression of interferon-stimulated genes in HepG2 cells by enhancing the activity of the interferon-stimulated response element (ISRE)].
    Yang K; Pan Y; Liu P; Yu F; Wei X; Zhang F; Wang Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Aug; 40(8):704-709. PubMed ID: 39215668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.
    Bisson SA; Page AL; Ganem D
    J Virol; 2009 May; 83(10):5056-66. PubMed ID: 19279093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
    Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
    Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Measles Virus V Protein Binding Site to STAT2 Overlaps That of IRF9.
    Nagano Y; Sugiyama A; Kimoto M; Wakahara T; Noguchi Y; Jiang X; Saijo S; Shimizu N; Yabuno N; Yao M; Gooley PR; Moseley GW; Tadokoro T; Maenaka K; Ose T
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MxA is a positive regulator of type I IFN signaling in HCV infection.
    Shi X; Jiao B; Chen Y; Li S; Chen L
    J Med Virol; 2017 Dec; 89(12):2173-2180. PubMed ID: 28561372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway.
    Matsumoto A; Ichikawa T; Nakao K; Miyaaki H; Hirano K; Fujimito M; Akiyama M; Miuma S; Ozawa E; Shibata H; Takeshita S; Yamasaki H; Ikeda M; Kato N; Eguchi K
    J Gastroenterol; 2009; 44(8):856-63. PubMed ID: 19436942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
    Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA
    Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.
    Yamauchi S; Takeuchi K; Chihara K; Honjoh C; Kato Y; Yoshiki H; Hotta H; Sada K
    Sci Rep; 2016 Dec; 6():38336. PubMed ID: 27929099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells.
    Kanda T; Jiang X; Nakamoto S; Nakamura M; Miyamura T; Wu S; Yokosuka O
    Cytokine; 2013 Nov; 64(2):577-83. PubMed ID: 24041672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.
    Watanabe T; Sugauchi F; Tanaka Y; Matsuura K; Yatsuhashi H; Murakami S; Iijima S; Iio E; Sugiyama M; Shimada T; Kakuni M; Kohara M; Mizokami M
    Gut; 2013 Sep; 62(9):1340-6. PubMed ID: 23135762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.
    Hazari S; Chandra PK; Poat B; Datta S; Garry RF; Foster TP; Kousoulas G; Wakita T; Dash S
    Virol J; 2010 Feb; 7():36. PubMed ID: 20149251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
    PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms.
    Verweij MC; Wellish M; Whitmer T; Malouli D; Lapel M; Jonjić S; Haas JG; DeFilippis VR; Mahalingam R; Früh K
    PLoS Pathog; 2015 May; 11(5):e1004901. PubMed ID: 25973608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9.
    Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ
    Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-induced mTOR activity exhibits anti-hepatitis C virus activity.
    Muraoka T; Ichikawa T; Taura N; Miyaaki H; Takeshita S; Akiyama M; Miuma S; Ozawa E; Isomoto H; Takeshima F; Nakao K
    Mol Med Rep; 2012 Feb; 5(2):331-5. PubMed ID: 22052332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
    Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
    J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
    Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
    Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.